Home/Replimune/Chris Sarchi
CS

Chris Sarchi

Chief Commercial Officer

Replimune

Therapeutic Areas

Replimune Pipeline

DrugIndicationPhase
RP1Advanced MelanomaPhase 2/3
RP2Metastatic Uveal MelanomaPhase 2/3